Einstein/Montefiore Department of Medicine

Department Faculty

Dr. Jeffrey E. Pessin, Ph.D.

Jeffrey E. Pessin, Ph.D.

Professor, Department of Medicine (Endocrinology)

Professor, Department of Molecular Pharmacology

Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research

Director, Diabetes Research Center, Department of Medicine

Areas of Research: Regulation of glucose metabolism Epigenetic modifications regulating metabolism Regulation of lipogenic gene transcription and de novo lipogenesis Program cell death adipocyte and liver biology Integrative metabolic signaling

Professional Interests

The Pessin laboratory is analyzing insulin signaling at the molecular level, the regulation of glucose uptake and metabolism at the cellular, molecular level and the integrative systems of metabolism in normal and pathophysiologic states in genetic rodent models. Our efforts have been focused on three major aspects of insulin signaling and insulin sensitivity. These areas include the molecular mechanisms of adipose tissue inflammation leading to fibrosis, the regulation of insulin signaling and skeletal muscle atrophy, and the signaling pathways mediating insulin stimulated lipogenesis and its dysregulation in states of insulin resistance.

One major laboratory project is the investigation of adipocyte progenitor cells, adipocyte programmed cell death and adipose tissue fibrosis that is induced by high fat feeding. In these studies, we have utilized a variety of experimental approaches including genetically engineered mice, Fluorescent Activated Cell Sorting (FACS) analyses and sorting along with quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). In these analyses we isolated a variety of inflammatory specific cell types within adipose tissue and have taken extensive use of RNAseq technology to characterize the expression profiles of these various cell subsets. This approach has allowed us to develop a functional understanding of the signaling interplay between the adipose tissue immune cell types to determine the specific role each cell is playing in the inflammatory response.

A second major laboratory project is based upon our recent findings that in the fed state CDK8/CycC complex directly phosphorylates the nuclear form of SREBP-1c that induces an E3 ligase mediated ubiquitination and proteasome-mediated degradation of SREBP-1c. This process is one of several that is required to maintain nuclear SREBP1-c at very low levels thereby suppresses lipogenic gene expression and lipogenesis. However, n the fed state, CDK8/CycC proteins are rapidly down regulated through a mTORC1 dependent pathway leading to increased SREBP-1c stability and increased lipogenic gene expression and lipogenesis. During the past two years, we have developed a robust research team, several key mouse genetic models and cell based approaches (primary rat hepatocytes and FAO cells) to investigate the regulation of liver lipogenesis in normal and pathophysiologic states of insulin resistance, obesity and non-alcoholic fatty liver disease (NFALD).

The final major emphasis of the laboratory is based upon the novel-signaling pathway between the non-receptor tyrosine kinase Fyn and the LKB1 tumor suppressor gene in regulating AMPK and mTORC1 signaling. This has opened a new area of investigation that directly related to the control of energy metabolisms and the balance between catabolic and anabolic control. We are now devoting a considerable effort to unravel these critical mechanisms that appears responsible for the control of skeletal muscle metabolism and muscle maintenance. During the course of these investigations we compared the phenotype of between the glycolytic muscle wasting of Fyn transgenic mice with that of Pompe disease mice and uncovered a critical aspect of Pompe disease resulting from the inability to activate mTORC1. We have examined the affect of a dietary intervention to reactivate mTORC1 that remarkable was able to almost completely prevent the muscle wasting and muscle dysfunction in Pompe mice. As such, we now propose to delineate the molecular mechanisms and signaling pathways mediating mTORC1 activation and the role of mTORC1 in autophagic vacuole and lysosome function that is dysfunctional in skeletal muscle of the Pompe mouse model.

Selected Publications

Zong, H., Wang, C.-C., Vaitheesvaran, B., Kurland, I.J., Hong, W. and Pessin, J.E.  Enhanced energy expenditure, glucose utilization and insulin sensitivity in VAMP8 null mice. Diabetes.  60:30-8, 2011.

Huang, P., Yeku, O., Zong, H., Tsang, P., Su, W., Yu, X., Teng, S., Osisami, M., Kanaho, Y., Pessin, J.E. and Frohman, M.A.  Phosphatidylinositol 4-phosphate 5-kinase (alpha) deficiency alters dynamics of glucose-stimulated insulin release to improve glucohomeostasis and decrease obesity in mice.  Diabetes. 60:454-63, 2011.

Feng, D., Tang, Y., Kwon, H.J, Zong, H., Hawkins, M., Kitsis, R.N. and Pessin, J.E. High Fat Diet Induced Adipocyte Cell Death Occurs Through a Cyclophilin D Intrinsic Signaling Pathway Independent of Adipose Tissue Inflammation. Diabetes, 60:2134-2143, 2011.

Zong, H., Armoni, M., Harel, C., Karnieli,E. and Pessin, J.E.  Cytochrome P450 CYP2E1 knockout mice are protected against high fat diet induced obesity and insulin resistance.  Am J Physiol., 302:E532-539, 2012.

Kaushik, S., Arias, E., Kwon, H., Martinez-Lopez, H., Sahu, S., Schwartz, G.J., Pessin, J.E. and Singh, R.  Loss of autophagy in hypothalamic POMC neurons impairs lipolysis.  EMBO Reports, 13:258-265, 2012.

Yamada, E., Bastie, C.C., Koga, H., Wang, Y., Cuervo, A.M and Pessin,J.E.  Mouse skeletal muscle fiber-type specific macroautophagy and muscle wasting is regulated by a Fyn/STAT3/Vps34 signaling pathway. Cell Reports, 1:557-569, 2012.

Zhao, X., Feng, D., Wang, Q., Abdulla, A., Xie, X-J., Zhou, J., Sun, Y., Yang, E.S., Liu, L-P., Vaitheesvaran, B., Bridges, L., Kurland, I.J., Strich, R., Ni, J-Q., Wang, C., Ericsson, J., Pessin, J.E., Ji, J-Y., and Yang, F.  Conserved regulation of lipid homeostasis by CDK8-mediated control of nuclear SREBP-1 stability. J. Clin. Invest., 122:2417-2427, 2012.

McKimpson, W.M., Weinberger, J., Czerski, L., Zheng, M., Crow, M.T., Pessin, J.E., Chua, S.C. Jr., and Kitsis, R.N. ARC is a novel apoptosis repressor in islets that inhibits the ER stress response to promote β-cell survival. Diabetes, In press, 2012.


More Information About Dr. Jeffrey Pessin

Diabetes Research and Training Center

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Albert Einstein College of Medicine
Michael F. Price Center
1301 Morris Park Avenue , Room 375
Bronx, NY 10461

Tel: 718.678.1029

Research Information

In the News

Modern Healthcare interviews Drs. Eric Bouhassira and Jeffrey Pessin in a cover story on federal and state stem cell funding. The cover, entitled, Dishing it Out, appears in the March 16th edition.

More media coverage